SynthesisFrontiers in public health2026
Association between current e-cigarette use and chronic obstructive pulmonary disease: a meta-analysis focusing on exclusive e-cigarette users.
Synthesis in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: While often promoted as a safer alternative to traditional cigarettes, electronic cigarettes (e-cigarettes) are linked to uncertain long-term health effects. Their independent relationship with chronic obstructive pulmonary disease (COPD) remains unclear, mainly due to the confounding effects of traditional cigarette use. This meta-analysis aimed to evaluate the association between current e-cigarette use and the prevalence of COPD. As a key secondary aim, we conducted a subgroup analysis focusing on exclusive e-cigarette users-individuals who currently use e-cigarettes but have never smoked traditional cigarettes-to preliminarily explore the independent association. Methods: A comprehensive literature search was conducted in PubMed, Embase, Web of Science, the Cochrane Library, China National Knowledge Infrastructure, and Wanfang Database for studies published up to 12 November 2025. Eligible observational studies that assessed the association between e-cigarette use and the prevalence of COPD were included, and pooled estimates were calculated using a random-effects model. Results: A total of 15 studies were included in the meta-analysis. Current e-cigarette use was associated with a significantly higher odds of having COPD (pooled odds ratio [OR] = 2.03, 95% confidence interval [CI]: 1.61-2.56). Former e-cigarette users also had an elevated association with COPD (OR = 1.82, 95% CI: 1.38-2.41). Subgroup analyses indicated the prevalence of COPD was higher among exclusive e-cigarette users (OR = 2.09, 95% CI: 1.46-3.00), dual users of e-cigarettes and traditional cigarettes (OR = 3.13, 95% CI: 2.01-4.87), and current e-cigarette users with a smoking history (OR = 2.17, 95% CI: 1.41-3.35). Sensitivity analysis supported the robustness of these findings, and no evidence of publication bias was observed. Conclusion: This meta-analysis suggests that current e-cigarette use is associated with a higher prevalence of COPD. This association remained evident among exclusive e-cigarette users, indicating a potential link independent of traditional smoking history. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251218716, identifier (CRD420251218716).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.